Sanjay Logani

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications
    Sanjay Logani
    Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Am J Surg Pathol 27:1434-41. 2003
  2. ncbi Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma
    Sanjay Logani
    Emory University School of Medicine, Atlanta, GA, USA
    Mod Pathol 18:19-25. 2005
  3. ncbi Vascular "pseudo invasion" in laparoscopic hysterectomy specimens: a diagnostic pitfall
    Sanjay Logani
    Department of Pathology, Emory University Hospital, Atlanta, GA 30322, USA
    Am J Surg Pathol 32:560-5. 2008
  4. ncbi Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis
    Ayse Ayhan
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Am J Surg Pathol 33:1220-4. 2009
  5. ncbi Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas
    Carlos S Moreno
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America
    PLoS ONE 2:e441. 2007
  6. ncbi Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
    Nathan J Bowen
    School of Biology, Georgia Institute of Technology, Atlanta, GA, USA
    BMC Med Genomics 2:71. 2009
  7. ncbi Well-differentiated fetal adenocarcinoma of the lung: cytomorphologic features on fine-needle aspiration with emphasis on use of beta-catenin as a useful diagnostic marker
    Lori Proctor
    Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA
    Diagn Cytopathol 35:39-42. 2007
  8. ncbi Oxidative stress induces ADAM9 protein expression in human prostate cancer cells
    Shian Ying Sung
    Molecular Urology and Therapeutics Program, Department of Urology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Cancer Res 66:9519-26. 2006
  9. ncbi Melanoma with cartilaginous differentiation: Diagnostic challenge on fine-needle aspiration with emphasis on differential diagnosis
    Krisztina Z Hanley
    Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia, USA
    Diagn Cytopathol 37:51-5. 2009
  10. ncbi Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
    Christopher D Scharer
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    J Transl Med 6:79. 2008

Detail Information

Publications15

  1. ncbi Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications
    Sanjay Logani
    Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Am J Surg Pathol 27:1434-41. 2003
    ..They also indicate that the morphologic similarity between TCC-O and TCC-B does not indicate any histogenic similarity and, as others have noted, TCC-O is a variant morphology in the spectrum of surface epithelial carcinomas...
  2. ncbi Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma
    Sanjay Logani
    Emory University School of Medicine, Atlanta, GA, USA
    Mod Pathol 18:19-25. 2005
    ..Diffuse expression of all three markers (CDX2, beta-catenin and P504S) in a tumor in the ovary was found to be virtually diagnostic of metastasis from a colorectal primary in this study...
  3. ncbi Vascular "pseudo invasion" in laparoscopic hysterectomy specimens: a diagnostic pitfall
    Sanjay Logani
    Department of Pathology, Emory University Hospital, Atlanta, GA 30322, USA
    Am J Surg Pathol 32:560-5. 2008
    ..Pathologists need to be aware of this artifact to avoid misinterpretation of vascular invasion in these cases with its associated therapeutic and prognostic implications...
  4. ncbi Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis
    Ayse Ayhan
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Am J Surg Pathol 33:1220-4. 2009
    ....
  5. ncbi Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas
    Carlos S Moreno
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America
    PLoS ONE 2:e441. 2007
    ....
  6. ncbi Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
    Nathan J Bowen
    School of Biology, Georgia Institute of Technology, Atlanta, GA, USA
    BMC Med Genomics 2:71. 2009
    ....
  7. ncbi Well-differentiated fetal adenocarcinoma of the lung: cytomorphologic features on fine-needle aspiration with emphasis on use of beta-catenin as a useful diagnostic marker
    Lori Proctor
    Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA
    Diagn Cytopathol 35:39-42. 2007
    ....
  8. ncbi Oxidative stress induces ADAM9 protein expression in human prostate cancer cells
    Shian Ying Sung
    Molecular Urology and Therapeutics Program, Department of Urology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Cancer Res 66:9519-26. 2006
    ..ADAM9 could be responsible for supporting prostate cancer cell survival and progression. By decreasing ADAM9 expression, we observed apoptotic cell death in prostate cancer cells...
  9. ncbi Melanoma with cartilaginous differentiation: Diagnostic challenge on fine-needle aspiration with emphasis on differential diagnosis
    Krisztina Z Hanley
    Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia, USA
    Diagn Cytopathol 37:51-5. 2009
    ..The differential diagnostic considerations are discussed...
  10. ncbi Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
    Christopher D Scharer
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    J Transl Med 6:79. 2008
    ..Recent data has shown that overexpression of Aurora-A can confer resistance to the taxane paclitaxel...
  11. ncbi The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis
    Reiko Dehari
    Department of Pathology, Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Am J Surg Pathol 31:1007-12. 2007
    ..The above results suggest that the majority of high-grade and low-grade carcinomas develop independently but in rare cases, a high-grade serous carcinoma may arise from an atypical proliferative serous (borderline) tumor...
  12. ncbi Emerging roles for PAX8 in ovarian cancer and endosalpingeal development
    Nathan J Bowen
    School of Biology, Georgia Institute of Technology, and Ovarian Cancer Institute, Atlanta, GA 30332, USA
    Gynecol Oncol 104:331-7. 2007
    ..Aberrant transcriptional expression of PAX8 has been reported in epithelial ovarian cancer, prompting us to initiate the molecular characterization of this master regulatory gene in ovarian cancer development...
  13. ncbi Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining
    Sanjay Logani
    Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA
    Mod Pathol 16:735-41. 2003
    ..In contrast, the majority (84%) of VAIN1 cases were associated with high-risk HPVs. In conclusion, MIB-1 staining is sensitive and specific for identifying VIN1/VAIN1, helpful in verifying the diagnosis in equivocal cases...
  14. ncbi Evaluation of the CD34 and CD10 immunostains using a two-color staining protocol in liver fine-needle aspiration biopsies
    Robert L Zimmerman
    Department of Pathology and Lab Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Diagn Cytopathol 32:88-91. 2005
    ..Two-color immunostaining with CD10 and CD34 may prove useful in distinguishing HCC from metastases...
  15. ncbi Molecular characterization of uterine clear cell carcinoma
    Hee-Jung An
    Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    Mod Pathol 17:530-7. 2004
    ..Additional molecular studies of pure clear cell carcinoma are required to further elucidate the genetic pathways involved in its development and progression...